DYN
Dyne Therapeutics, Inc.
Stock
$15.20−0.62 (−3.92%)Close Oct 2, 2026
- Research and development, 2025
- $398M
- YoY, 2025
- +41.6%
- 5-year CAGR
- +54.5%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $398M | +41.6% |
| 2024 | $281M | +33.5% |
| 2023 | $211M | +47.6% |
| 2022 | $143M | +17.7% |
| 2021 | $121M | +168.4% |
| 2020 | $45M | +309.4% |
| 2019 | $11M | — |